1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. SAREPTA THERAPEUTICS INC
Sarepta Therapeutics Inc
XNAS: SRPT

Sarepta Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The comp...

Read More
20.30 -0.12 (-0.59%)
68.67% Fall from 52W High
2.1M
XNAS Volume

XNAS 24 Apr, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Sarepta Therapeutics Inc is on 06 May 2026 for the purpose of Sarepta Therapeutics Inc First Quarter Earnings Result for 2026 See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
25.7 / 100
Momentum Score
Technically Neutral
51.2 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
22
1Yr Price target upside is 7%
23 analysts

7

S

15

W

5

O

1

T

SWOT Analysis

Sarepta Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..